Clinical Trial Update: Phase I Study of Intrathecal Mafosfamide [Phase 1]

View source ↗

Summary

A Phase I trial of intrathecal mafosfamide has completed. The update lists leukemia, lymphoma, and meningeal neoplasms as conditions studied.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Meningeal Neoplasm

Drugs mentioned

• mafosfamide (mafosfamide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED